Ghent University Academic Bibliography

Advanced

Can zoledronic acid treatment improve bone strength parameters assessed by PQCT: a pilot study

Stefan Goemaere UGent, Hans-Georg Zmierczak UGent, AH Batens, Bruno Lapauw UGent, Kaatje Toye UGent, HILDA VLIEGHE UGent, REIN DEMUYNCK UGent, MELISSA MASSCHELIN UGent, Jean Kaufman UGent and C Bucci-Rechtweg, et al. (2010) OSTEOPOROSIS INTERNATIONAL. 21(suppl. 1). p.57-58
Please use this url to cite or link to this publication:
author
organization
alternative title
year
type
conference
publication status
published
subject
in
OSTEOPOROSIS INTERNATIONAL
Osteoporosis Int.
volume
21
issue
suppl. 1
pages
57 - 58
conference name
IOF World congress on Osteoporosis ; 10th European congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis
conference location
Florence, Italy
conference start
2010-05-05
conference end
2010-05-08
Web of Science type
Meeting Abstract
Web of Science id
000277299400118
JCR category
ENDOCRINOLOGY & METABOLISM
JCR impact factor
4.859 (2010)
JCR rank
23/115 (2010)
JCR quartile
1 (2010)
ISSN
0937-941X
language
English
UGent publication?
yes
classification
C3
id
2136462
handle
http://hdl.handle.net/1854/LU-2136462
date created
2012-06-07 18:23:26
date last changed
2012-06-26 16:29:00
@inproceedings{2136462,
  author       = {Goemaere, Stefan and Zmierczak, Hans-Georg and Batens, AH and Lapauw, Bruno and Toye, Kaatje and VLIEGHE, HILDA and DEMUYNCK, REIN and MASSCHELIN, MELISSA and Kaufman, Jean and Bucci-Rechtweg, C and Black, DM},
  booktitle    = {OSTEOPOROSIS INTERNATIONAL},
  issn         = {0937-941X},
  language     = {eng},
  location     = {Florence, Italy},
  number       = {suppl. 1},
  pages        = {57--58},
  title        = {Can zoledronic acid treatment improve bone strength parameters assessed by PQCT: a pilot study},
  volume       = {21},
  year         = {2010},
}

Chicago
Goemaere, Stefan, Hans-Georg Zmierczak, AH Batens, Bruno Lapauw, Kaatje Toye, HILDA VLIEGHE, REIN DEMUYNCK, et al. 2010. “Can Zoledronic Acid Treatment Improve Bone Strength Parameters Assessed by PQCT: a Pilot Study.” In Osteoporosis International, 21:57–58.
APA
Goemaere, S., Zmierczak, H.-G., Batens, A., Lapauw, B., Toye, K., VLIEGHE, H., DEMUYNCK, R., et al. (2010). Can zoledronic acid treatment improve bone strength parameters assessed by PQCT: a pilot study. OSTEOPOROSIS INTERNATIONAL (Vol. 21, pp. 57–58). Presented at the IOF World congress on Osteoporosis ; 10th European congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis.
Vancouver
1.
Goemaere S, Zmierczak H-G, Batens A, Lapauw B, Toye K, VLIEGHE H, et al. Can zoledronic acid treatment improve bone strength parameters assessed by PQCT: a pilot study. OSTEOPOROSIS INTERNATIONAL. 2010. p. 57–8.
MLA
Goemaere, Stefan, Hans-Georg Zmierczak, AH Batens, et al. “Can Zoledronic Acid Treatment Improve Bone Strength Parameters Assessed by PQCT: a Pilot Study.” Osteoporosis International. Vol. 21. 2010. 57–58. Print.